Hormone therapy can make a big difference for men with recurrent or metastatic prostate cancer. But it isn't a cure. Its effects are limited and the side effects can be difficult to cope with.

ANDROGEN deprivation therapy (ADT) has been the cornerstone of treatment for advanced castration-sensitive prostate cancer ...

When prostate cancer has metastasized, and hormone therapy is no longer effective, or when chemotherapy fails or causes ...

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in ...

The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

Opens in a new tab or window In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen deprivation therapy (ADT) and chemotherapy more ...

The global hormone-sensitive advanced prostate cancer treatment market is projected to achieve a valuation of USD 12.44 ...

Prostate cancer is Australia's most commonly diagnosed ... delaying the need for hormone therapy or chemotherapy.

Prostate cancer treatment options, including stereotactic radiation therapy, effectiveness, side effects, and cost ...